Anesiva to Host Conference Call and Webcast Tomorrow to Discuss Encouraging Development in Zingo(T...(for painmanagement and an overview of th...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Anesiva to Host Conference Call and Webcast Tomorrow to Discuss Encouraging Development in Zingo(TM) Program
Date:8/19/2007
for pain management, and an overview of the clinical challenges being addressed by its product candidates, go to http://www.anesiva.com.
'/>"/>
SOURCE Anesiva, Inc. Copyright©2007 PR Newswire. |
Related biology technology :
1. Digital Healthcare Conference 2007: Mounting obstacles for health IT
2. Biomedical engineering conference invites manufacturers
3. Conference to address small town development
4. Wisconsin to host SBIR Conference
5. Gaming conference explores interactive media in learning
6. Digital Healthcare Conference starts on a realistic note
7. Digital Healthcare Conference marks Wisconsins Healthcare IT Week
8. Third coast of biotechnology makes strong showing at VC conference
9. Why companies dont get invited to the DEMO conference
10. Giuliani will keynote RedPrairie Corporations user conference
11. Wicab to present BrainPort at Boston conference
Post Your Comments:
Breaking Biology Technology:AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 2AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 3Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 2Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 2RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 4RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 5RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 6Alberta companies delivering new products to the health & medical marketplace 2
[0] AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia[0] Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures [0] RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE)[0] Alberta companies delivering new products to the health & medical marketplace
Other Biology Technology:Seed-Stage Venture Financing 2Seed-Stage Venture Financing 3Seed-Stage Venture Financing 4Seed-Stage Venture Financing 5SBIR/STTR Programs: Free Money or an Invitation to Governmental Bureaucracy 2SBIR/STTR Programs: Free Money or an Invitation to Governmental Bureaucracy 3
Breaking Biology News(10 mins):Improving the odds 2Study shows nearly 1/3 of human genome is involved in gingivitis 2Study shows nearly 1/3 of human genome is involved in gingivitis 3White, but not pure 2White, but not pure 3Nicholas Vogelzang MD Joins US Oncology Research Network via Comprehensive Cancer Centers of Nevada 54335 1Nicholas Vogelzang MD Joins US Oncology Research Network via Comprehensive Cancer Centers of Nevada 54335 2Nicholas Vogelzang MD Joins US Oncology Research Network via Comprehensive Cancer Centers of Nevada 54335 3Nicholas Vogelzang MD Joins US Oncology Research Network via Comprehensive Cancer Centers of Nevada 54335 4Atherotech Adds New Cardiometabolic Tests Amid Strong 2009 Growth 54331 1Atherotech Adds New Cardiometabolic Tests Amid Strong 2009 Growth 54331 2Perfect Fitness Ranks No 1 of Consumer Product Companies on 2009 Inc 500 List Ranks No 4 Overall 54327 1Perfect Fitness Ranks No 1 of Consumer Product Companies on 2009 Inc 500 List Ranks No 4 Overall 54327 2
Other Biology News:Allscripts Integrates Electronic Health Records with Innovative Patient Kiosk 2Allscripts Integrates Electronic Health Records with Innovative Patient Kiosk 3Allscripts Integrates Electronic Health Records with Innovative Patient Kiosk 4Allscripts Integrates Electronic Health Records with Innovative Patient Kiosk 5Allscripts Integrates Electronic Health Records with Innovative Patient Kiosk 6Allscripts Integrates Electronic Health Records with Innovative Patient Kiosk 7Nutrition experts propose new class of low-sugar drinks to help stem obesity and diabetes epidemics 2Nutrition experts propose new class of low-sugar drinks to help stem obesity and diabetes epidemics 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |